Table 4.
Distribution of the groups examined, according to sex and age, and criteria for defining the viremia controller and non-controller groups.
| Groups According to Disease Progression | Males Age (Range) |
Females Age (Range) |
Length of Infection (Years) | CD4 + T Lymphocytes | HIV-1 Viral Load | Remarks |
|---|---|---|---|---|---|---|
|
VC1 VIREMIA CONTROLLERS1 |
1 (52) |
1 (45) |
>6 | >500 cells/mm3 | <50 copies/mL | No episodes of viral load increase; CD4+ T > 500 cells/mm3 in 90% of measurements; stable for more than 6 years; no ART intervention |
|
VC2 VIREMIA CONTROLLERS 2 |
3 (34–47) |
5 (35–53) |
>6 | >500 cells/mm3 | ≤log104 (≤10,000 copies/mL) | Episodes of increased HIV-1 viral load; decrease in CD4+ TL in ~40% of counts; natural remission to regular levels without ART intervention |
|
NC NON-VIREMIA CONTROLLERS |
16 (28–68) |
12 (24–68) |
>6 | <500 cells/mm3 | >log104 (>10,000 copies/mL) |